AI Scribes – Helping independent mental health providers save time

Ambient scribing software, when combined with generative AI, can convert speech directly into structured medical documentation such as notes and letters. The products are sometimes referred to as ambient scribes or AI scribes and include ambient voice technologies used for clinical or patient documentation and workflow support. This means that the clinician can focus on the patient in front of them, rather than focusing on a computer screen, with confidence that their conversation will be captured into an accurate draft summarisation for review and validation.

Access Rio Smart Notes is our take on the ambient voice technology, integrating with our Rio EPR to help optimise patient record upkeep.

In an independent mental health setting, AI scribes serve three specific workflows:

• Session note generation: The scribe listens to a therapy session and produces a structured draft document based on the conversation. The clinician reviews the notation, edits where necessary, and then approves the document to proceed into the EPR. There is still an element of administration, but it’s far quicker – and far less reliant on a clinician’s recollection – than previously so.
• Psychiatric assessment drafting: An initial psychiatric assessment generates a large volume of structured documentation: history of presenting complaint, mental state examination, risk assessment, formulation, and treatment plan. Machine learning and pattern recognition gives an understanding of templates/forms, which means some AI scribes can produce a working draft of all of these from the consultation itself, reducing post-appointment admin from hours to minutes
• Care plan population: For providers using an electronic patient record, AI-generated content can flow directly into structured care plan fields - think targets, interventions, review dates, risk management steps - rather than being typed manually from memory. This solves a big risk regarding human fallibility and recollection amidst a busy working day.

An AI medical scribe typically captures or accepts encounter audio, produces a transcript or structured draft, and gives a clinician a route to edit and approve the result. The question is not whether a scribe uses AI but whether the complete workflow produces a safe, usable record with acceptable effort and governance. The technology is not the hard part, the governance is.

The NHS rollout of AI scribes has generated a substantial body of guidance. NHS England published its ambient scribing framework in April 2025 (updated April 2026) and the Royal College of Psychiatrists and NHS England announced in May 2026 that they are developing guidance for Ambient Voice Technology in clinical practice with people with mental health needs, learning disabilities, or neurodivergent people.

That guidance is NHS-facing. Independent providers are not bound by it, but they cannot ignore it either. It sets the standard against which any provider, NHS or independent, will be judged if something goes wrong.

Therapy is not a standard clinical encounter. What is disclosed in a therapy session - trauma histories, suicidal ideation, sexual identity, relationship violence, psychotic experiences - sits at the most sensitive end of the personal data spectrum.

Documentation burden varies significantly across specialties, with mental health practitioners uniquely affected because note-taking during therapy may disrupt the therapeutic alliance in ways that may not apply in the same way to, for example, a dermatology or physiotherapy appointment.

This is the distinction that matters. A GP using an AI scribe to document a blood pressure review is operating in a different risk environment from a psychiatrist using one to document a first episode psychosis assessment. The data is undoubtedly more sensitive and the patient is more vulnerable. The therapeutic relationship depends on a level of trust that ambient recording technology can either support or undermine, depending entirely on how it is introduced.

There are three key questions that independent providers must answer regarding the implementation and usage of AI scribes.

1. Clinical governance: who is responsible for notes?

AI scribes are not just admin tools. They are information governance and patient trust tools. The governance questions go beyond "does the note look accurate?" and extend to consent, objection, privacy, vulnerable patients, clinical appropriateness, record accuracy, and how ambient listening fundamentally changes the dynamics of the clinical consultation.

For independent providers, clinical governance means establishing clear answers to four questions before a single session is recorded:

• Who reviews and approves every AI-generated note before it enters the patient record?
• What is the escalation path if the AI produces a clinically inaccurate draft?
• How are risk indicators (suicidal ideation, safeguarding concerns, capacity issues) handled if they appear in an AI-generated note but were not flagged by the clinician?
• What is the audit trail if a patient or regulator requests evidence of how a note was produced?

AI informed consent policies should define the technology strictly as a documentation scribe and not as a co-therapist or diagnostic tool. AI clinical documentation policies must include a human-in-the-loop guarantee to ensure practitioners review and edit all generated notes for accuracy.

The human-in-the-loop requirement is not optional. It is the governance foundation on which everything else rests. An AI scribe that produces notes which go into the record without clinician review is a liability.

NHS England's guidance on the safe use of AI in health and care reinforced that AI systems must meet clear clinical safety, regulatory, and information governance standards before widescale deployment. Independent providers deploying AI scribes without equivalent internal standards are operating below the bar the sector has already set.

2. Patient consent: what the law actually requires

This is where independent mental health providers face their sharpest obligation, and where most commonly mistakes are made.

A mental health session turned into a privacy breach when an AI tool logged confidential discussions without consent. Healthcare providers are rushing to adopt automated tools for paperwork, but a therapist's secret use of an AI scribe exposed a breach of trust, which in turn sparked urgent questions about digital privacy boundaries and the unchecked integration of automation in highly sensitive medical settings.

That case is a preview of what happens when providers treat consent as a box to tick rather than a clinical obligation to fulfil.

Valid explicit consent under GDPR has a precise legal meaning. It must be:

• Freely given, i.e. the patient must not face any detriment for refusing;
• Specific - consent to recording does not imply consent to transcription, AI processing, or sharing with a supervisor;
• Informed - the patient must understand what they are consenting to, including who will process their data and how;
• Unambiguous - a pre-ticked box or passive acceptance does not meet the standard; and
• Explicit - for special category data, the consent must be expressed clearly and actively.

A therapist who obtains a patient's signature on a general therapy agreement has not thereby obtained consent to run session audio through an AI transcription service.

For independent mental health providers, this means consent to AI scribing must be:

• Obtained separately from the general therapy or treatment agreement
• Explained in plain language - what is recorded, where it is processed, who can access it, and how long it is retained
• Genuinely voluntary - patients who decline must receive the same standard of care without any friction or disadvantage
• Revisable - patients can withdraw consent at any time, and the process for doing so must be straightforward

Patients should be told at the beginning of the session if an ambient scribe is being used, and patients can ask for one not to be used. The guidance covers use for individual care and does not extend to research use or training of new AI products, which have different legal requirements.

If a vendor's terms of service allow session data to be used for model training - even in anonymised form - that is a separate processing purpose that requires separate consent. Providers must read vendor data processing agreements carefully before signing.

3. GDPR compliance: data residency, processor agreements, and special category obligations

Recording or transcribing a remote therapy session is both a technical decision and a legal one. Under GDPR, mental health information sits at the highest level of data sensitivity, and the obligations that flow from that classification affect every independent practitioner and institutional clinician who uses a digital documentation tool.

For independent providers in England, the practical GDPR checklist for AI scribe deployment covers five areas:

• Data residency. Where is session audio processed and stored? UK-based processing is the lowest-risk position. Providers should require vendors to confirm data residency in writing, not just in marketing materials.
• Data processor agreements. Any vendor processing patient data on behalf of a provider is a data processor under UK GDPR. A signed Data Processing Agreement is a legal requirement, not a commercial nicety. While vendors may use truly anonymised data outside the scope of UK GDPR, they must be able to demonstrate that anonymisation is irreversible and independently assessed. Any reuse of identifiable or re-identifiable data for training purposes without an appropriate legal basis is unlawful.
• Data minimisation. Does the scribe retain the full session audio after the note is generated, or is it deleted? Retaining raw audio of therapy sessions creates a data liability that far exceeds the clinical value. Providers should require audio deletion post-processing as a contractual term.
• Subject access rights. Patients have the right to access their data, including AI-generated notes and, potentially, transcripts. Providers need a clear process for handling subject access requests that includes AI-generated content.
• Special category processing. For special category mental health data, the risk level is high by default. A Data Protection Impact Assessment is required before deploying any AI scribe in a mental health setting. This is not optional under UK GDPR, it is a legal obligation for high-risk processing.

In 2026, the Medicines and Healthcare products Regulatory Agency (MHRA) will publish a new regulatory framework for AI in healthcare. This is being informed by the work of the National Commission into the Regulation of AI in Healthcare.

Work is currently underway by the MHRA and the National Commission into the Regulation of AI in Healthcare to develop a new national regulatory framework for AI in healthcare, which will be published in 2026. The new framework will apply to AI tools classified as a medical device.

Whether an AI scribe constitutes a medical device under the new framework depends on its intended purpose. A tool that generates draft notes for clinician review sits in a different regulatory category from one that flags clinical risk or makes diagnostic suggestions. Independent providers should be asking vendors directly: what is your MHRA classification, and what does that mean for how we deploy you?

Beyond GDPR, psychologists and psychiatrists should be aware of the EU Artificial Intelligence Act, which is being phased in through 2026. AI systems used in healthcare, including those that process psychological assessment data, may be classified as high-risk under the Act. High-risk AI systems face requirements around transparency, human oversight, data quality, and documentation.

The providers who build their governance frameworks now, before the MHRA framework lands, will be better positioned than those who wait for regulation to force their hand.

Governance questions are not reasons to avoid AI scribes. They are the conditions under which AI scribes can be deployed safely. Providers who answer them clearly will get the efficiency gains. Those who skip them will get the liability.

A 2025 peer-reviewed narrative review in Digital Health found that AI tools in mental health frequently operate in legal grey areas regarding consent, data usage, and cross-border data flows, and that GDPR offers only baseline protections that do not yet account for the unique ethical and clinical nuances of AI-based mental health interventions.

That gap is the reason to build internal standards that exceed minimum expectations.

For independent mental health providers using an electronic patient record, the infrastructure question matters as much as the governance question. An AI scribe that generates a note in a separate system (one that then has to be manually copied into the clinical record) has not solved the documentation problem, it has moved it. The value of AI-generated documentation is realised when the output flows directly into the structured fields of the EPR: the care plan, the risk assessment, the clinical correspondence. That requires an EPR with the integration architecture to receive it – like Access Rio Smart Notes.